Philip Thomas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Philip Thomas has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Michael Fenech
CSIRO Division of Food and Nutritional Sciences 13 Kintore Avenue PO Box 10041 5000 Adelaide Adelaide BC South Australia Australia
7 shared publications- Michael Fenech
Health and Biomedical Innovation, UniSA Clinical and Health Sciences, University of South Australia, Adelaide 5000, Australia
3 shared publications - Cristiano Trindade
Universidad Simón Bolívar, Facultad de Ciencias Básicas y Biomédicas, Barranquilla, Colombia
2 shared publications - João Antonio Pêgas Henriques
Universidade de Caxias do Sul, Brazil
2 shared publications - Luciane Macedo de Menezes
Department of Orthodontics, School of Health and Life Sciences (Dental Program) Pontifical Catholic University of Rio Grande Do Sul Porto Alegre Brazil
2 shared publications - Tatiana Siqueira Gonçalves
Department of Orthodontics, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, RS, Brazil
2 shared publications
Latest Publications
- 1 September 2015
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 791, 25-29
In vivo evaluation of the genotoxic effects of Hyrax auxiliary orthodontic appliances containing silver-soldered joints
- 1 September 2015
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 791, 25-29
In vivo evaluation of the genotoxic effects of Hyrax auxiliary orthodontic appliances containing silver-soldered joints
- 1 March 2014
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 762, 1-8
Cytotoxicity and genotoxicity of orthodontic bands with or without silver soldered joints
- 1 March 2014
- Published by Elsevier in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
- Vol. 762, 1-8
Cytotoxicity and genotoxicity of orthodontic bands with or without silver soldered joints
- Open Access
- 1 January 2012
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 9 (1) , 35
The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis
Glutathione has a wide range of functions; it is an endogenous anti-oxidant and plays a key role in the maintenance of intracellular redox balance and detoxification of xenobiotics. Several studies have indicated that children with autism spectrum disorders may have altered glutathione metabolism which could play a key role in the condition.
- 1 January 2012
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 9 (1) , 35
Open AccessThe potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis
Glutathione has a wide range of functions; it is an endogenous anti-oxidant and plays a key role in the maintenance of intracellular redox balance and detoxification of xenobiotics. Several studies have indicated that children with autism spectrum disorders may have altered glutathione metabolism which could play a key role in the condition.
- Open Access
- 16 December 2010
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 26 (1) , 69-76
Effect of dietary intervention on human micronucleus frequency in lymphocytes and buccal cells
Successful maintenance of accurate DNA replication and repair is critical to human health. Once this homeostatic balance is impaired, genomic instability events occur, compromising the integrity of the genome, which may initiate fundamental events leading to human diseases. Biomarkers of DNA damage, such as the micronucleus (MN) index, are elevated both in developmental and degenerative diseases and have been shown to be predictive of increased cancer risk and cardiovascular disease mortality. Several micronutrients have been identified as being effective in reducing and/or protecting against DNA damage. Micronutrients act as co-factors for enzymes required in DNA repair or maintenance of methylation patterns essential for optimal gene expression. In this review, published human intervention studies are examined with respect to the efficacy of micronutrient supplementation in reducing MN frequency in both lymphocytes and buccal cells. Important knowledge gaps and future research directions are also explored. The outcomes of these studies suggest that supplementation with antioxidant vitamins and certain B vitamins may cause a substantial reduction in MN frequency.
- 16 December 2010
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 26 (1) , 69-76
Open AccessEffect of dietary intervention on human micronucleus frequency in lymphocytes and buccal cells
Successful maintenance of accurate DNA replication and repair is critical to human health. Once this homeostatic balance is impaired, genomic instability events occur, compromising the integrity of the genome, which may initiate fundamental events leading to human diseases. Biomarkers of DNA damage, such as the micronucleus (MN) index, are elevated both in developmental and degenerative diseases and have been shown to be predictive of increased cancer risk and cardiovascular disease mortality. Several micronutrients have been identified as being effective in reducing and/or protecting against DNA damage. Micronutrients act as co-factors for enzymes required in DNA repair or maintenance of methylation patterns essential for optimal gene expression. In this review, published human intervention studies are examined with respect to the efficacy of micronutrient supplementation in reducing MN frequency in both lymphocytes and buccal cells. Important knowledge gaps and future research directions are also explored. The outcomes of these studies suggest that supplementation with antioxidant vitamins and certain B vitamins may cause a substantial reduction in MN frequency.
- 15 October 2010
- Published by Springer Nature
- Vol. 682, 235-248
Buccal Micronucleus Cytome Assay
The Buccal Micronucleus Cytome (BMCyt) assay is a new minimally invasive system for studying DNA damage, chromosomal instability, cell death, and the regenerative potential of buccal mucosal tissue. This method is increasingly being used in molecular epidemiologic studies investigating the impact of nutrition, life-style factors, genotoxin exposure, and genotype on DNA damage and cell death. Biomarkers of this assay have been associated with increased risk for accelerated aging, cancer, and neurodegenerative diseases. This protocol describes the current established methods for buccal cell collection, slide preparation, cellular and nuclear staining, and scoring criteria.
- 15 October 2010
- Published by Springer Nature
- Vol. 682, 235-248
Buccal Micronucleus Cytome Assay
The Buccal Micronucleus Cytome (BMCyt) assay is a new minimally invasive system for studying DNA damage, chromosomal instability, cell death, and the regenerative potential of buccal mucosal tissue. This method is increasingly being used in molecular epidemiologic studies investigating the impact of nutrition, life-style factors, genotoxin exposure, and genotype on DNA damage and cell death. Biomarkers of this assay have been associated with increased risk for accelerated aging, cancer, and neurodegenerative diseases. This protocol describes the current established methods for buccal cell collection, slide preparation, cellular and nuclear staining, and scoring criteria.
- 1 April 2008
- Published by Elsevier in Mechanisms of Ageing and Development
- Vol. 129 (4) , 183-190
Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease
- 1 April 2008
- Published by Elsevier in Mechanisms of Ageing and Development
- Vol. 129 (4) , 183-190
Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease
- 1 February 2008
- Published by Elsevier in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Vol. 638 (1-2) , 37-47
The buccal cytome and micronucleus frequency is substantially altered in Down's syndrome and normal ageing compared to young healthy controls
- 1 February 2008
- Published by Elsevier in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Vol. 638 (1-2) , 37-47
The buccal cytome and micronucleus frequency is substantially altered in Down's syndrome and normal ageing compared to young healthy controls
- Open Access
- 29 November 2007
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 23 (1) , 57-65
Chromosome 17 and 21 aneuploidy in buccal cells is increased with ageing and in Alzheimer's disease
Alzheimer's disease (AD) is a premature ageing syndrome characterized by cognitive impairment arising from neuropathological changes occurring within specific areas of the brain. We report a 1.5-fold increase in trisomy 21 (P < 0.001) and a 1.2-fold increase in trisomy 17 (P < 0.001) in buccal cells of Alzheimer's patients compared to age- and gender-matched controls. Chromosome 17 and chromosome 21 monosomy and trisomy increase significantly with age (P < 0.001). Down's syndrome, which exhibits similar neuropathological features to those observed in AD also showed a strong increase in chromosome 17 monosomy and trisomy compared to matched controls (P < 0.001). These results suggest that an increased incidence of aneusomy for both chromosomes 17 and 21 may contribute to the aetiology of AD. We also investigated aneuploidy rates in hippocampal brain cells, which have been shown to have a low rate of cell division, which may be relevant in potential incidence of non-disjunction. However, aneuploidy rate for chromosomes 17 and 21 in the nuclei of hippocampus cells of brains from Alzheimer's patients and controls were not significantly different. These results are suggestive that the aneuploidy events investigated which are increased beyond the incidence in normal ageing may be influenced by genetic factors that may predispose to AD, but are unlikely to be a primary cause of AD brain pathology.
- 29 November 2007
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 23 (1) , 57-65
Open AccessChromosome 17 and 21 aneuploidy in buccal cells is increased with ageing and in Alzheimer's disease
Alzheimer's disease (AD) is a premature ageing syndrome characterized by cognitive impairment arising from neuropathological changes occurring within specific areas of the brain. We report a 1.5-fold increase in trisomy 21 (P < 0.001) and a 1.2-fold increase in trisomy 17 (P < 0.001) in buccal cells of Alzheimer's patients compared to age- and gender-matched controls. Chromosome 17 and chromosome 21 monosomy and trisomy increase significantly with age (P < 0.001). Down's syndrome, which exhibits similar neuropathological features to those observed in AD also showed a strong increase in chromosome 17 monosomy and trisomy compared to matched controls (P < 0.001). These results suggest that an increased incidence of aneusomy for both chromosomes 17 and 21 may contribute to the aetiology of AD. We also investigated aneuploidy rates in hippocampal brain cells, which have been shown to have a low rate of cell division, which may be relevant in potential incidence of non-disjunction. However, aneuploidy rate for chromosomes 17 and 21 in the nuclei of hippocampus cells of brains from Alzheimer's patients and controls were not significantly different. These results are suggestive that the aneuploidy events investigated which are increased beyond the incidence in normal ageing may be influenced by genetic factors that may predispose to AD, but are unlikely to be a primary cause of AD brain pathology.
- Open Access
- 20 August 2007
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 22 (6) , 371-379
Buccal micronucleus cytome biomarkers may be associated with Alzheimer's disease
Alzheimer's disease (AD) is a progressive degenerative disorder of the brain and is the commonest form of dementia. A buccal cytome assay was used to measure ratios of buccal cell populations and micronuclei in clinically diagnosed Alzheimer's patients compared to age and gender-matched controls. Frequencies of basal cells (P < 0.0001), condensed chromatin cells (P < 0.0001) and karyorrhectic cells (P < 0.0001) were found to be significantly lower in Alzheimer's patients. These changes may reflect alterations in the cellular kinetics or structural profile of the buccal mucosa, and may be useful as potential biomarkers in identifying individuals with a high risk of developing AD. The odds ratio of being diagnosed with AD for those individuals with a basal cell plus karyorrhectic cell frequency <41 per 1000 cells is 140, with a specificity of 97% and sensitivity of 82%. These promising results need to be replicated in larger studies and in cohorts of other neurodegenerative disorders to determine specificity of changes to Alzheimer's patients.
- 20 August 2007
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 22 (6) , 371-379
Open AccessBuccal micronucleus cytome biomarkers may be associated with Alzheimer's disease
Alzheimer's disease (AD) is a progressive degenerative disorder of the brain and is the commonest form of dementia. A buccal cytome assay was used to measure ratios of buccal cell populations and micronuclei in clinically diagnosed Alzheimer's patients compared to age and gender-matched controls. Frequencies of basal cells (P < 0.0001), condensed chromatin cells (P < 0.0001) and karyorrhectic cells (P < 0.0001) were found to be significantly lower in Alzheimer's patients. These changes may reflect alterations in the cellular kinetics or structural profile of the buccal mucosa, and may be useful as potential biomarkers in identifying individuals with a high risk of developing AD. The odds ratio of being diagnosed with AD for those individuals with a basal cell plus karyorrhectic cell frequency <41 per 1000 cells is 140, with a specificity of 97% and sensitivity of 82%. These promising results need to be replicated in larger studies and in cohorts of other neurodegenerative disorders to determine specificity of changes to Alzheimer's patients.